Globalspace Technologies launches new product ‘PATGPT’

25 Sep 2025 Evaluate

Globalspace Technologies has launched a new product ‘PATGPT - A Pharma-specific Large Language Model (LLM) Platform. PATGPT is a ready-to-deploy AI solution designed specifically for pharmaceutical enterprises. It will operate under a hybrid model wherein 50% of the training has been carried out on pharmaceutical datasets by GlobalSpace, and the remaining 50% will be trained using proprietary datasets of pharmaceutical companies within their secure cloud environments.

This approach positions PATGPT both as a product and as a customized LLM training service, enabling pharma companies to securely build organization-specific AI intelligence. In the initial phase, PATGPT will focus on sales, marketing, inventory, and distribution optimization. The future roadmap includes expansion into R&D, clinical trials, pharmacovigilance, and regulatory submissions. 

Globalspace Technologies is a Software Product Platform Company with focus on Enterprise Mobility SaaS based solutions, providing integrated software & hardware product platforms and solutions to enable large and medium enterprises embrace mobility & digital technology for their business enhancement.


Globalspace Tech Share Price

15.48 -0.12 (-0.77%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
TCS 3238.90
Infosys 1615.95
HCL Tech. 1682.85
Wipro 260.00
Tech Mahindra 1569.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×